Etorica-P Tablet is a combination medication containing Etoricoxib 60mg and Paracetamol 325mg, designed to provide effective relief from pain and inflammation. Etoricoxib is a selective COX-2 inhibitor that works by reducing the production of prostaglandins, substances responsible for pain and inflammation in the body, making it particularly useful in managing conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain. Paracetamol, also known as acetaminophen, is a widely used analgesic and antipyretic agent that helps alleviate mild to moderate pain and reduce fever by inhibiting the synthesis of prostaglandins in the central nervous system. The combination of these two active ingredients offers a synergistic effect, providing enhanced pain relief while minimizing gastrointestinal side effects commonly associated with non-selective NSAIDs. Etorica-P is typically prescribed for short-term use to manage acute pain and inflammation, and it should be taken as directed by a healthcare professional. Patients with liver or kidney impairment, cardiovascular conditions, or a history of gastrointestinal ulcers should use this medication cautiously. It is important to avoid exceeding the recommended dose to prevent potential adverse effects such as liver toxicity or cardiovascular risks.